Recently, a novel multiplexed electrochemical biosensor for the simultaneous detection of CRC-specific autoantibodies in plasma samples was developed by Garranzo-Asensio et al. [48], similarly to that previously reported for a single tumor-associated antigen (TAA) (p53) [131]. Here, TP53 is linked to colorectal carcinoma.